| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.33 | 0.0001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0002 |